Phase 1 11 trials
Phase 1
NCT07734610 Sep 2026 → Feb 2027 expected —
Merck Sharp & Dohme LLC
Recruiting
No outcome recorded
Phase 1
NCT07232589 Dec 2025 → May 2026 —
Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 1
NCT06442436 Jul 2024 → Aug 2026 —
Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 1
NCT06625827 Nov 2023 → Jan 2024 —
Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 1
NCT06688045 Oct 2023 → Jan 2024 —
Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 1
NCT06772818 Oct → Dec 2023 —
Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 1
NCT06586671 Aug → Nov 2023 hematopoietic and lymphoid cell neoplasm Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 1
NCT06698016 Jul → Oct 2023 —
Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 1
NCT06772805 Jul → Dec 2023 —
Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 1
NCT05673460 Feb 2023 → Apr 2025 neoplasm of mature B-cells Merck Sharp & Dohme LLC
Completed
No outcome recorded
Phase 1
NCT05347225 Jun 2022 → Apr 2027 expected hematopoietic and lymphoid cell neoplasm Merck Sharp & Dohme LLC
Active not recruiting
No outcome recorded
Show 1 more trial Phase 1/2 1 trial
Phase 1/2
NCT03162536 Jun 2017 → Sep 2027 expected Richter transformation , Waldenstrom macroglobulinemia , chronic lymphocytic leukemia/small lymphocytic lymphoma , diffuse large B-cell lymphoma +3 ArQule, Inc.
Active not recruiting
No outcome recorded
Phase 2 11 trials
Phase 2
NCT07583810 Dec 2026 → May 2028 expected gastric mucosa-associated lymphoid tissue lymphoma , nodal marginal zone B-cell lymphoma , primary lymphoma of the conjunctiva , splenic marginal zone lymphoma City of Hope Medical Center
Recruiting
No outcome recorded
Phase 2
NCT06863402 Nov 2026 → Jun 2029 expected B-cell chronic lymphocytic leukemia , Richter transformation , diffuse large B-cell lymphoma Roswell Park Cancer Institute
Recruiting
No outcome recorded
Phase 2
NCT07194980 Oct 2026 → Oct 2029 expected chronic lymphocytic leukemia/small lymphocytic lymphoma Fred Hutchinson Cancer Center
Recruiting
No outcome recorded
Phase 2
NCT07796373 Oct 2026 → Dec 2030 expected chronic lymphocytic leukemia/small lymphocytic lymphoma National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
No outcome recorded
Phase 2
NCT07690891 Oct 2026 → Dec 2029 expected chronic lymphocytic leukemia/small lymphocytic lymphoma Medical College of Wisconsin
Not yet recruiting
No outcome recorded
Phase 2
NCT07557056 Sep 2026 → Dec 2027 expected chronic lymphocytic leukemia/small lymphocytic lymphoma Jennifer Woyach
Not yet recruiting
No outcome recorded
Phase 2
NCT07673367 Jul 2026 → Jul 2031 expected mantle cell lymphoma Vanderbilt-Ingram Cancer Center
Not yet recruiting
No outcome recorded
Phase 2
NCT07464210 Jun 2026 → Aug 2029 expected Waldenstrom macroglobulinemia Seoul National University Hospital
Not yet recruiting
No outcome recorded
Phase 2
NCT06572618 Jan 2025 → Jan 2027 expected mantle cell lymphoma City of Hope Medical Center
Recruiting
No outcome recorded
Phase 2
NCT05458297 Jul 2022 → May 2029 expected B-cell chronic lymphocytic leukemia , Richter transformation , follicular lymphoma , mantle cell lymphoma Merck Sharp & Dohme LLC
Active not recruiting
No outcome recorded
Phase 2
NCT04728893 Apr 2021 → Jan 2029 expected Waldenstrom macroglobulinemia , chronic lymphocytic leukemia/small lymphocytic lymphoma Merck Sharp & Dohme LLC
Recruiting
No outcome recorded
Show 1 more trial Phase 3 3 trials
Phase 3
NCT06136559 Dec 2023 → Sep 2032 expected chronic lymphocytic leukemia/small lymphocytic lymphoma Merck Sharp & Dohme LLC
Recruiting
No outcome recorded
Phase 3
NCT05947851 Aug 2023 → Jun 2032 expected chronic lymphocytic leukemia/small lymphocytic lymphoma Merck Sharp & Dohme LLC
Recruiting
No outcome recorded
Phase 3
NCT05624554 Mar 2023 → May 2027 expected chronic lymphocytic leukemia/small lymphocytic lymphoma Merck Sharp & Dohme LLC
Active not recruiting
No outcome recorded